Encompass Health Corp
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2.3% | +2.1% | +2.5% | +1.1% | +1.2% | +1.6% | +2.2% | +1.2% | +3.3% | +3.2% | +2.0% | |
| – | +3.5% | +10.5% | +0.9% | -0.4% | -5.0% | +2.7% | +0.8% | -5.3% | +4.2% | +13.6% | +1.2% | |
| – | -26.2% | +65.7% | +5.4% | +9.2% | -57.1% | +12.2% | +43.4% | -64.6% | +111.3% | +58.8% | -34.1% | |
| – | -20.5% | +101.5% | +4.8% | -20.0% | -64.3% | +12.2% | +78.1% | -71.5% | +197.9% | +38.2% | -46.3% | |
| – | +14.1% | +1.3% | -4.8% | -2.3% | +3.9% | +4.1% | -1.7% | -0.3% | +1.4% | +9.2% | +1.7% | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +3.0% | +2.5% | +2.4% | +2.7% | +4.1% | – | – | |
| – | +0.0% | +0.0% | +0.2% | +0.0% | +0.0% | +0.0% | +1.5% | +0.0% | +1.1% | +0.0% | +0.4% | |
| – | +0.7% | -2.2% | +11.3% | -2.2% | +0.5% | -1.1% | +0.5% | -1.4% | +5.6% | -2.6% | +2.2% | |
| – | +0.8% | +0.6% | +0.8% | -3.3% | -1.3% | +0.5% | -0.2% | -0.5% | +3.7% | +3.5% | +1.3% | |
| – | +2.7% | +3.6% | +2.1% | +29.2% | -6.3% | +1.8% | +1.1% | -11.9% | +9.8% | +4.8% | -0.4% | |
| – | +0.2% | +4.3% | +15.9% | +339.1% | -36.5% | +0.3% | -0.4% | -60.6% | +8.0% | -0.4% | -9.2% | |
| – | -71.2% | -2.3% | -1.1% | +3.7% | +0.4% | -7.0% | +9.7% | -20.7% | +28.8% | +14.5% | +8.6% | |
| – | -0.2% | -0.2% | +0.1% | -12.7% | +0.6% | -1.1% | -0.6% | +3.2% | +2.2% | +3.4% | +2.7% | |
| – | +5.6% | +5.7% | +5.6% | +6.5% | +5.5% | +4.5% | +5.6% | +4.1% | +2.7% | +3.4% | +3.0% | |
| – | +21.6% | +23.9% | +19.6% | +15.1% | +14.9% | +16.8% | +13.4% | +10.1% | +10.9% | +13.6% | +9.2% | |
| – | +0.1% | +0.7% | -0.2% | +0.1% | +0.2% | -0.2% | +0.1% | +0.1% | -0.3% | -1.4% | -0.6% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.